Lisinopril: Difference between revisions
| Line 136: | Line 136: | ||
Lisinopril does not undergo metabolism and is excreted entirely unchanged into the urine. On multiple dosing lisinopril has an effective half-life of 12.6 hours. The clearance of lisinopril in healthy subjects is approximately 50 ml/min. | Lisinopril does not undergo metabolism and is excreted entirely unchanged into the urine. On multiple dosing lisinopril has an effective half-life of 12.6 hours. The clearance of lisinopril in healthy subjects is approximately 50 ml/min. | ||
< | <u>Renal impairment</u> | ||
Impaired renal function decreases elimination of lisinopril, which is excreted via the kidneys, but this decrease becomes clinically important only when the glomerular filtration rate is below 30 ml/min. | Impaired renal function decreases elimination of lisinopril, which is excreted via the kidneys, but this decrease becomes clinically important only when the glomerular filtration rate is below 30 ml/min. | ||
Revision as of 23:01, 21 August 2022
Pronunciation
Lisinopril 10mg
Lisinopril 20mg
Lisinopril 5mg
| Generic Name: | Lisinopril |
|---|---|
| Class: | Cardiovascular Drug |
| Subclass: | ACE inhibitors |
| Legal Classification: | P1S1S3 |
Drug Names
| Generic Name 藥物化學名稱 | HA Code 藥物代碼 | Legal Classification法律藥物分類 | Brand Name 藥名 |
|---|---|---|---|
| Lisinorpil Tablet 5mg | LISI01 | P1S1S3 | |
| Lisinorpil Tablet 10mg | LISI02 | P1S1S3 | |
| Lisinorpil Tablet 20mg | LISI03 | P1S1S | ZESTRIL |
Mechanism of Action
Lisinopril is an inhibitor of angiotensin-I converting enzyme (ACE inhibitor). The beneficial effects of ACE inhibitors appear to result primarily from the suppression of the plasma renin-angiotensin-aldosterone system. Renin is synthesized by the kidneys and released into the circulation where it converts angiotensinogen to angiotensin-I. Angiotensin-I is then converted by angiotensin converting enzyme to angiotensin-II. Angiotensin-II is a potent vasoconstrictor responsible for arterial vasoconstriction and increased blood pressure, as well as for stimulation of the adrenal gland to secrete aldosterone. Inhibition of ACE results in decreased plasma angiotensin-II, which leads to decreased vasopressor activity and to reduced aldosterone secretion. The latter decrease may result in an increase in serum potassium concentration. Lisinopril is used in the treatment of hypertension and heart failure. It also improves your survival if you are taking it after a recent heart attack of for heart failure. It works by widening your blood vessels and making it easier for your heart to pump blood around your body. It can also be used for diabetic kidney disease, to slow down the disease.
Lisinopril comes as tablet.
Route of Administration
Lisinopril is administered orally in a single daily dose. The absorption of Lisinopril tablet is not affected by food.
Dosage
Hypertension
Adult: initially 10 mg once daily; maintenance 20 mg once daily; maximum 80 mg/day.
Heart failure
Adult: initially 2.5 mg once daily, increased in steps of up to 10 mg at least every 2 weeks; maximum 35 mg per day if tolerated.
Diabetic kidney disease 10 mg to 20 mg once daily
The antihypertensive effects of lisinopril are seen within 1 to 2 hours of a single oral dose and the maximum effect occurs after about 6 hours, although the full effect may not develop for several weeks during chronic dosing.
The haemodynamic action lasts for about 24 hours after once-daily dosing.
Side Effects
| System Organ Class | Frequency | Adverse reactions |
|---|---|---|
| Nervous system disorders | Common | Dizziness, headache, |
| Uncommon | Confusion, sleep disturbances | |
| Respiratory disorders | Common | Dry, itickly (non-productive) cough, dyspnoea |
| Skin disorders | Uncommon | Itching or a mild skin rash |
| rare | Alopecia, oedema of the face, extremities, lips, tongue, glottis, and/or larynx | |
| Gastro-intestinal disorders | Common | vomiting, diarrhoea |
| Uncommon | Nausea, abdominal pain and indigestion | |
| Rare | Dry mouth | |
| Very rare | Glossitis, pancreatitis | |
| Cardiac disorders | UnCommon | Palpitations, tachycardia |
| Vascular disorder | common | Hypotension |
| Uncommon | Raynaud’s syndrome |
Pharmacokinetics
Following oral administration of lisinopril, peak serum concentrations occur within about 7 hours, although there was a trend to a small delay in time taken to reach peak serum concentrations in acute myocardial infarction patients. Lisinopril absorption is not affected by the presence of food. Lisinopril does not undergo metabolism and is excreted entirely unchanged into the urine. On multiple dosing lisinopril has an effective half-life of 12.6 hours. The clearance of lisinopril in healthy subjects is approximately 50 ml/min.
Renal impairment Impaired renal function decreases elimination of lisinopril, which is excreted via the kidneys, but this decrease becomes clinically important only when the glomerular filtration rate is below 30 ml/min.
